| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-29 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-236
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-62 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-29 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-236
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-62 |
| filingDate |
1980-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1983-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cedbc4fd9c2d03b14dadb01a1508d32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_101c47881a882db71b09dabdd1bc4a75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6a3a165e056611a39bc68333ac85a9f |
| publicationDate |
1983-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-1158579-A |
| titleOfInvention |
Antibiotic ar-5 complex, derivatives thereof and methods for production thereof |
| abstract |
Disclosed are novel macrolide antibiotics of the formula I I wherein R is H or OH and A represents a double bond between the carbon atoms of positions 12 and 13 or, together with the carbon atoms of positions 12 and 13 an oxirane ring, as well as the pharmaceutically acceptable esters and salts thereof, The compounds can be prepared by fermentation of the novel species designated Micromonospora polytrota (e.g. M. poly-trota NRRL 12066). The compounds show antibacterial activity. |
| priorityDate |
1979-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |